CVRX INC. - COMMON STOCK
6.7300
25-4月-25 16:45:00
15 分の遅延
株式
+0.2500
+3.86%
本日の幅
6.3750 - 6.9600
ISIN
N/A
ソース
NASDAQ
-
CVRx Announces Key Senior Leadership Team Hires
16 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports First Quarter 2024 Financial and Operating Results
30 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
16 4 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx announces availability of additional data supporting long-term benefits of Barostim
15 4 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
31 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
25 1 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
11 1 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
08 1 2024 08:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27 12 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx receives FDA approval for expanded labeling of Barostim
26 12 2023 08:05:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
15 11 2023 16:21:43 提供 Nasdaq GlobeNewswire
-
CMS Increases Outpatient Payment for Barostim Procedure
03 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Third Quarter 2023 Financial and Operating Results
26 10 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference
27 7 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports Second Quarter 2023 Financial and Operating Results
25 7 2023 16:15:00 提供 Nasdaq GlobeNewswire
-
11 7 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Set to Join Russell 2000 & 3000 Indexes
22 6 2023 16:30:00 提供 Nasdaq GlobeNewswire
-
CVRx to Present at the William Blair 43rd Annual Growth Stock Conference
25 5 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
CVRx Reports First Quarter 2023 Financial and Operating Results
27 4 2023 16:15:00 提供 Nasdaq GlobeNewswire